Mainz Biomed BV Financial Flexibility Index

Latest as of December 2025: -0.95x

Mainz Biomed BV financial flexibility index. Mainz Biomed BV (MYNZ) has a Financial Flexibility Index of -0.95x as of December 2025. Free cash flow of $-4.46 Million (operating CF $-4.46 Million minus capex $93.00) represents -1% of total liabilities ($4.69 Million).

Financial Flexibility Index

-0.95x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-4.46 Million
Operating CF − Capex

Total Liabilities

$4.69 Million
USD

Capital Expenditures

$93.00
USD

Financial Flexibility Index of Mainz Biomed BV (2019–2025)

Financial flexibility index of Mainz Biomed BV from 2019 to 2025. Historical Financial Flexibility Index trend for Mainz Biomed BV across 7 annual periods. Explore MYNZ cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Mainz Biomed BV Financial Flexibility Index by Year (2019–2025)

Mainz Biomed BV financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Mainz Biomed BV. For the full cash flow conversion analysis, see cash efficiency ratio of Mainz Biomed BV.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -2.34x $-10.98 Million $-10.98 Million $4.69 Million ▼ -0.1%
2024 -2.34x $-16.84 Million $-17.09 Million $7.19 Million ▼ -42.0%
2023 -1.65x $-20.04 Million $-21.94 Million $12.16 Million ▲ +28.2%
2022 -2.30x $-14.11 Million $-14.77 Million $6.14 Million ▼ -163.8%
2021 -0.87x $-3.20 Million $-3.22 Million $3.68 Million ▼ -547.7%
2020 -0.13x $-459.05K $-468.74K $3.41 Million ▲ +11.9%
2019 -0.15x $-406.81K $-416.50K $2.67 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities